A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Recruiting · NCT07215923 · Registry updated 2025-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers | Arterial Occlusive Diseases, Chemically-Induced Disorders, cardiovascular disorder, nicotine dependence, psychiatric disorder, substance-related disorder, thromboangiitis obliterans, vascular disorder, vasculitis | Recruiting | Phase 1 | 2025-10-15 | NCT07215923 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Antidote Therapeutics, Inc | 1 |
| National Institute on Drug Abuse (NIDA) | 549 |
| National Institutes of Health (NIH) | 667 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dr. Vince Clinical Research | Overland Park | United States | 8 |